» Articles » PMID: 35535905

Human Umbilical Cord-derived Mesenchymal Stem Cells Promote Repair of Neonatal Brain Injury Caused by Hypoxia/ischemia in Rats

Overview
Date 2022 May 10
PMID 35535905
Authors
Affiliations
Soon will be listed here.
Abstract

Administration of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) is believed to be an effective method for treating neurodevelopmental disorders. In this study, we investigated the possibility of hUC-MSCs treatment of neonatal hypoxic/ischemic brain injury associated with maternal immune activation and the underlying mechanism. We established neonatal rat models of hypoxic/ischemic brain injury by exposing pregnant rats to lipopolysaccharide on day 16 or 17 of pregnancy. Rat offspring were intranasally administered hUC-MSCs on postnatal day 14. We found that polypyrimidine tract-binding protein-1 (PTBP-1) participated in the regulation of lipopolysaccharide-induced maternal immune activation, which led to neonatal hypoxic/ischemic brain injury. Intranasal delivery of hUC-MSCs inhibited PTBP-1 expression, alleviated neonatal brain injury-related inflammation, and regulated the number and function of glial fibrillary acidic protein-positive astrocytes, thereby promoting plastic regeneration of neurons and improving brain function. These findings suggest that hUC-MSCs can effectively promote the repair of neonatal hypoxic/ischemic brain injury related to maternal immune activation through inhibition of PTBP-1 expression and astrocyte activation.

Citing Articles

Umbilical mesenchymal stem cells mitigate T-cell compartments shift and Th17/Treg imbalance in acute ischemic stroke via mitochondrial transfer.

Chen S, Han C, Shi Z, Guan X, Cheng L, Wang L Stem Cell Res Ther. 2025; 16(1):134.

PMID: 40075467 PMC: 11905603. DOI: 10.1186/s13287-025-04224-6.


hUC-MSCs Prevent Acute High-Altitude Injury through Apoe/Pdgf-b/p-Erk1/2 Axis in Mice.

Yan S, Bi Y, Liu Q, Song S, Ma L, Ji G Stem Cell Rev Rep. 2025; .

PMID: 39871082 DOI: 10.1007/s12015-024-10840-1.


Mitochondrial-targeted therapies in traumatic brain injury: From bench to bedside.

Tabassum S, Wu S, Lee C, Yang B, Gusdon A, Choi H Neurotherapeutics. 2024; 22(1):e00515.

PMID: 39721917 PMC: 11840356. DOI: 10.1016/j.neurot.2024.e00515.


[Repair effect of different doses of human umbilical cord mesenchymal stem cells on white matter injury in neonatal rats].

Zhang J, Li M, Wang C, Xu Q, Zhang S, Zhu Y Zhongguo Dang Dai Er Ke Za Zhi. 2024; 26(4):394-402.

PMID: 38660904 PMC: 11057307. DOI: 10.7499/j.issn.1008-8830.2310081.


Transplantation of human placental chorionic plate-derived mesenchymal stem cells for repair of neurological damage in neonatal hypoxic-ischemic encephalopathy.

Xue L, Du R, Bi N, Xiao Q, Sun Y, Niu R Neural Regen Res. 2024; 19(9):2027-2035.

PMID: 38227532 PMC: 11040304. DOI: 10.4103/1673-5374.390952.


References
1.
Li M, Li C, Yu H, Cai X, Shen X, Sun X . Lentivirus-mediated interleukin-1β (IL-1β) knock-down in the hippocampus alleviates lipopolysaccharide (LPS)-induced memory deficits and anxiety- and depression-like behaviors in mice. J Neuroinflammation. 2017; 14(1):190. PMC: 5607621. DOI: 10.1186/s12974-017-0964-9. View

2.
Xian P, Hei Y, Wang R, Wang T, Yang J, Li J . Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics. 2019; 9(20):5956-5975. PMC: 6735367. DOI: 10.7150/thno.33872. View

3.
Canetta S, Bao Y, Co M, Ennis F, Cruz J, Terajima M . Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring. Am J Psychiatry. 2014; 171(5):557-63. PMC: 4025955. DOI: 10.1176/appi.ajp.2013.13070943. View

4.
Chavez C, Oyarzun J, Avendano B, Mellado L, Inostroza C, Alvear T . The Opening of Connexin 43 Hemichannels Alters Hippocampal Astrocyte Function and Neuronal Survival in Prenatally LPS-Exposed Adult Offspring. Front Cell Neurosci. 2019; 13:460. PMC: 6797550. DOI: 10.3389/fncel.2019.00460. View

5.
Imai K, Kotani T, Tsuda H, Nakano T, Ushida T, Iwase A . Administration of molecular hydrogen during pregnancy improves behavioral abnormalities of offspring in a maternal immune activation model. Sci Rep. 2018; 8(1):9221. PMC: 6003913. DOI: 10.1038/s41598-018-27626-4. View